Role of galactomannan determinations in bronchoalveolar lavage fluid samples from critically ill patients with chronic obstructive pulmonary disease for the diagnosis of invasive pulmonary aspergillosis: a prospective study

Critical Care

Volumn 16, Issue 4, 2012, Pages

  He, Hangyong ^a   Ding, Lin ^a   Sun, Bing ^a   Li, Fang ^a   Zhan, Qingyuan ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Bronchoalveolar lavage; Chronic obstructive pulmonary disease; Galactomannan; Intensive care unit; Invasive pulmonary aspergillosis

Indexed keywords

ANTIBIOTIC AGENT; GALACTOMANNAN; STEROID; BIOLOGICAL MARKER; MANNAN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BRONCHUS SECRETION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CRITICALLY ILL PATIENT; FEMALE; FUNGUS CULTURE; FUNGUS ISOLATION; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; LUNG ASPERGILLOSIS; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; OPTICAL DENSITY; PRIORITY JOURNAL; APACHE; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; CHEMISTRY; COMPLICATION; CRITICAL ILLNESS; ENZYME LINKED IMMUNOSORBENT ASSAY; HOSPITAL MORTALITY; INVASIVE PULMONARY ASPERGILLOSIS; MIDDLE AGED; MORTALITY; MYCOLOGY; PREDICTIVE VALUE; PROCEDURES; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; APACHE; BIOMARKERS; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; CRITICAL ILLNESS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; INVASIVE PULMONARY ASPERGILLOSIS; MALE; MANNANS; MIDDLE AGED; MYCOLOGY; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SENSITIVITY AND SPECIFICITY;

EID: 84864205475     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc11443     Document Type: Article

References (31)

1. Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 2001, 32:358-366. 10.1086/318483, 11170942.
2. Ader F, Nseir S, Berre RL, Leroy S, Tillie-Leblond I, Marquette C, Durocher A. Invasive pulmonary aspergillosis in chronic obstructive pulmonary disease: an emerging fungal pathogen. Clin Microbiol Infect 2005, 11:427-429. 10.1111/j.1469-0691.2005.01143.x, 15882191.
3. Meersseman W, Vandecasteele SJ, Wilmer A, Verbeken E, Peetermans WE, Wijngaerden EV. Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med 2004, 170:621-625. 10.1164/rccm.200401-093OC, 15229094.
4. Bulpa P, Dive A, Sibille Y. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur Respir J 2007, 30:782-800. 10.1183/09031936.00062206, 17906086.
5. Zhan Q, He H, Tong Z, Li F, Sun B, Wang C. Clinical features of invasive pulmonary aspergillosis in critically ill patients with chronic respiratory diseases. Zhonghua Jie He He Hu Xi Za Zhi 2008, 31:282-286.
6. Muquim A, Dial S, Menzies D. Invasive aspergillosis in patients with chronic obstructive pulmonary diseases. Can Respir J 2005, 12:199-204.
7. Dimopoulos G, Piagnerelli M, Berre J, Eddafali B, Salmon I, Vincent JL. Disseminated aspergillosis in intensive care unit patients: an autopsy study. J Chemother 2003, 15:71-75.
8. Samarakoon P, Soubani A. Invasive pulmonary aspergillosis in patients with COPD: a report of five cases and systematic review of the literature. Chronic Respiratory Disease 2008, 5:19-21. 10.1177/1479972307085637, 18303098.
9. He H, Ding L, Chang S, Li F, Zhan Q. Value of consecutive galactomannan determinations for the diagnosis and prognosis of invasive pulmonary aspergillosis in critically ill chronic obstructive pulmonary disease. Med Mycol 2011, 49:345-351. 10.3109/13693786.2010.521523, 20936913.
10. He H, Ding L, Li F, Zhan Q. Clinical features of invasive bronchial-pulmonary aspergillosis in critically ill patients with chronic obstructive respiratory diseases: a prospective study. Crit Care 2011, 15:R5. 10.1186/cc9402, 3222032, 21211008.
11. Segal BH. Aspergillosis. N Engl J Med 2009, 360:1870-1884. 10.1056/NEJMra0808853, 19403905.
12. Maertens J, Eldere JV, Verhaegen J, Verbeken E, Verschakelen J, Boogaerts M. Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients. J Infect Dis 2002, 186:1297-1306. 10.1086/343804, 12402199.
13. Maertens J, Verhaegen J, Lagrou K, Van Eldere J, Boogaerts M. Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood 2001, 97:1604-1610. 10.1182/blood.V97.6.1604, 11238098.
14. Pfeiffer C, Fine J, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis 2006, 42:1417-1427. 10.1086/503427, 16619154.
15. Maertens J, Maertens V, Theunissen K, Meersseman W, Meersseman P, Meers S, Verbeken E, Verhoef G, Van Eldere J, Lagrou K. Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases. Clin Infect Dis 2009, 49:1688-1693. 10.1086/647935, 19886801.
16. Pauw BD, Walsh T, Donnelly J, Stevens D, Edwards J, Calandra T, Pappas P, Maertens J, Lortholary O, Kauffman C, Denning D, Patterson T, Maschmeyer G, Bille J, Dismukes W, Herbrecht R, Hope W, Kibbler C, Kullberg B, Marr K, Munoz P, Odds F, Perfect J, Restrepo A, Ruhnke M, Segal B, Sobel J, Sorrell T, Viscoli C, Wingard J, Zaoutis T, Bennett J, . EORTC/MSG Consensus Group Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008, 46:1813-1821. 10.1086/588660, 2671227, 18462102, EORTC/MSG Consensus Group.
17. Guinea J, Torres-Narbona M, Gijon P, Munoz P, Pozo F, Pelaez T, de Miguel J, Bouza E. Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome. Clin Microbiol Infect 2010, 16:870-877.
18. Husain S, Paterson DL, Studer SM, Crespo M, Pilewski J, Durkin M, Wheat JL, Johnson B, McLaughlin L, Bentsen C, McCurry KR, Singh N. Aspergillus galactomannan antigen in the bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in lung transplant recipients. Transplantation 2007, 83:1330-1336. 10.1097/01.tp.0000263992.41003.33, 17519782.
19. Meersseman W, Lagrou K, Maertens J, Wijngaerden EV. Invasive aspergillosis in the intensive care unit. Clin Infect Dis 2007, 45:205-216. 10.1086/518852, 17578780.
20. Mennink-Kersten MA, Donnelly JP, Verweij PE. Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect Dis 2004, 4:349-357. 10.1016/S1473-3099(04)01045-X, 15172343.
21. Stuck AE, Minder CE, Frey FJ. Risk of infectious complications in patients taking glucocorticosteroids. Rev Infect Dis 1989, 11:954-963. 10.1093/clinids/11.6.954, 2690289.
22. Balloy V, Huerre M, Latge JP, Chignard M. Differences in patterns of infection and inflammation for corticosteroid treatment and chemotherapy in experimental invasive pulmonary aspergillosis. Infect Immun 2005, 73:494-503. 10.1128/IAI.73.1.494-503.2005, 538925, 15618189.
23. Tony TC, Robson GD, Denning DW. Hydrocortisone-enhanced growth of Aspergillus spp.: implications for pathogenesis. Microbiology 1994, 140:2475-2479. 10.1099/13500872-140-9-2475, 7952197.
24. Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis 2006, 42:1417-1427. 10.1086/503427, 16619154.
25. Perfect J, Cox G, Lee J, Kauffman C, de Repentigny L, Chapman S, Morrison V, Pappas P, Hiemenz J, Stevens D, . Mycoses Study Group The impact of culture isolation of Aspergillus species: A hospital-based survey of aspergillosis. Clin Infect Dis 2001, 33:1824-1833. 10.1086/323900, 11692293, Mycoses Study Group.
26. Tanriover MD, Metan G, Altun B, Hascelik G, Uzun O. False positivity for Aspergillus antigenemia related to the administration of piperacillin/tazobactam. Eur J Intern Med 2005, 16:489-491. 10.1016/j.ejim.2005.04.007, 16275542.
27. Meersseman W, Lagrou K, Maertens J, Wilmer A, Hermans G, Vanderschueren S, Spriet I, Verbeken E, Van Wijngaerden E. Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. Am J Respir Crit Care Med 2008, 177:27-34.
28. Bulpa P, Dive A. Diagnosis of invasive bronchial-pulmonary aspergillosis in patients with chronic obstructive respiratory diseases. Crit Care 2011, 15:420. author reply 420, 10.1186/cc10138, 3219395, 21542895.
29. Xu H, Li L, Huang WJ, Wang LX, Li WF, Yuan WF. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: a case control study from China. Clin Microbiol Infect 2012, 18:403-408. 10.1111/j.1469-0691.2011.03503.x, 22023558.
30. Ader F. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: an emerging fungal disease. Curr Infect Dis Rep 2010, 12:409-416. 10.1007/s11908-010-0132-1, 21308548.
31. Aquino VR, Nagel F, Andreolla HF, de-Paris F, Xavier MO, Goldani LZ, Denning DW, Pasqualotto AC. The performance of real-time PCRr, galactomannan, and fungal culture in the diagnosis of invasive aspergillosis in ventilated patients with chronic obstructive pulmonary disease (COPD). Mycopathologia 2012, 174:163-169. 10.1007/s11046-012-9531-1, 22382738.